As we move into Q2, FSA wishes everyone well on the Easter holidays.
Author Archives: Fund Selector Asia
In case you missed it (09 April 2020)
Schroders creates Singapore CEO role; Fund buyers look at alts; Chinese companies lack ESG policies; and more…
Robo-advisor performance: March 2020
All portfolios had their steepest monthly declines in March since the coronavirus outbreak started.
FSA Client Update: April 2020
Gareth Wilde, Managing director, Asia shares a video update with our clients during this challenging time in the region.
China Top Trumps – Greater China equities
This week FSA presents a quick comparison of two Greater China equity products: the NB China Equity Fund and the Value Partners Classic Fund.
Mutual Fund Top Trumps – North America equities
This week FSA presents a quick comparison of two North America equity products: the SJP North American Fund and the Wells Fargo Worldwide US All Cap Growth Fund.
Under the microscope: disruption in healthcare
Disease treatment is changing rapidly, leading to new therapies and better long-term results for patients — and creating investment opportunities, according to Andy Acker, portfolio manager, Janus Henderson Global Life Sciences and Dan Lyons, research analyst.
Robo-advisor performance: February 2020
As global markets tumbled last month, all aggressive portfolios had steep declines in February but still beat their respective benchmarks.
China Top Trumps – Greater China equities
This week FSA presents a quick comparison of two Greater China equity products: the AB China Opportunity Portfolio Fund and the New Capital China Equity Fund.
Mutual Fund Top Trumps – India equities
This week FSA presents a quick comparison of two India equity products: the BlackRock GF India Fund and the First State Indian Subcontinent Fund.
